The Szent-Györgyi Prize for Progress in Cancer Research is named in honor of Albert Szent-Györgyi, M.D., Ph.D. who was a pioneer, and, like many other explorers, he challenged the conventional thinking of the day to pursue his novel and promising ideas. After winning the Nobel Prize for his study on vitamin C and cell respiration, Dr. Szent-Györgyi set his sights on finding a way to defeat cancer.
Beyond his laboratory, Dr. Szent-Györgyi was a leading advocate for developing resources to provide scientists with the financial support necessary to pursue novel cancer research ideas. In 1973, he changed the face of cancer research funding by co-founding NFCR with entrepreneur Franklin C. Salisbury. Since then, NFCR has provided more than $275 million in support of cancer research and revention education programs.
NFCR is committed to upholding Dr. Szent-Györgyi's vision of curing cancer through innovation and collaboration. As part of this commitment, NFCR has established this Prize to honor scientists who have made extraordinary progress in cancer research and to focus attention on the essential role of basic research in finding the still elusive answers to the mysteries of cancer.
The Szent-Györgyi Prize serves to stimulate continued investment in the pioneering research that will produce scientific breakthroughs and lead to a deeper understanding of the scientific concepts behind the genetics and molecular makeup of cancer. By calling attention annually to achievements in this area, it is our desire to heighten awareness of the kind of research and discovery that must be accomplished before we can hope to produce cancer cures.
No comments:
Post a Comment